Back to CYTR Stock Lookup

CytRx (CYTR) – Press Releases

Jul 24, 2015 11:00 AM CytRx Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Jul 21, 2015 08:45 AM CytRx Announces Pricing of Public Offering of 9.1 Million Shares of Common Stock
Jul 20, 2015 04:01 PM CytRx Announces Proposed Public Offering of Common Stock
Jul 9, 2015 10:00 AM Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
Jun 30, 2015 09:00 AM CytRx Unveils Novel LADRâ„¢ (Linker Activated Drug Release) Technology Platform
Jun 29, 2015 09:00 AM CytRx Announces Presentation of Interim Phase 2 Data for Aldoxorubicin for HIV-Related Kaposi's Sarcoma
Jun 24, 2015 09:00 AM Cheryl Cohen, Former Medivation Chief Commercial Officer, Joins CytRx Board of Directors
Jun 2, 2015 09:00 AM CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware
May 27, 2015 09:00 AM CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting
May 26, 2015 09:00 AM CytRx to Present at the Jefferies 2015 Global Healthcare Conference
May 21, 2015 09:00 AM CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer)
May 4, 2015 09:00 AM CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers
May 1, 2015 09:00 AM CytRx Reports First Quarter 2015 Financial Results
Apr 29, 2015 09:00 AM CytRx Announces Publication of Glioblastoma Clinical Case Study in Journal of Nuclear Medicine & Radiation Therapy
Mar 11, 2015 09:00 AM Dr. Anita J. Chawla Joins CytRx Board of Directors to Add Additional Drug Commercialization Expertise in Oncology
Mar 10, 2015 06:00 AM CytRx Reports 2014 Financial Results

Back to CYTR Stock Lookup